Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
4.570
-0.080 (-1.72%)
At close: Oct 8, 2025, 4:00 PM EDT
4.730
+0.160 (3.50%)
After-hours: Oct 8, 2025, 7:48 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $356.72 million as of October 8, 2025. Its market cap has decreased by -52.14% in one year.
Market Cap
356.72M
Enterprise Value
43.75M
1-Year Change
-52.14%
Ranking
Category
Stock Price
$4.57
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has decreased from $467.51M to $356.72M, a decrease of -23.70%. That is a compound annual growth rate of -3.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 362.96M | -61.05% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 245.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |